Lower open on disappointing jobs data

The markets opened lower with the Dow losing 20 points to 17,048 as fewer jobs than expected were added to the nation's economy. Nasdaq slipped 5 points to 4,556.

On the upside

The Food and Drug Administration granted Orphan Drug designation to Prana Biotechnolgy's (Nasdaq: PRAN) Huntington Disease treatment PBT2.

Ambarella (Nasdaq: AMBA) reported higher second quarter earnings and revenue that beat analyst expectations.

Infoblox (NYSE: BLOX) fell to a loss for the fourth quarter but the results were better than expected.

On the downside

Quiksilver (NYSE: ZQK) fell to a greater than expected loss on lower revenue.

Sportswear Holdings will sell its 5.7% stake in Michael Kors (NYSE: KORS) at the discounted price of $76.75 per share.

Gap (NYSE: GPS) disappointed with a greater than expected 2% drop in same store sales last month.

In the broad market, advancing issues edged out decliners by a margin of nearly 10 to 9 on the NYSE while decliners outpaced advancers by 7 to 5 on Nasdaq. The broader S&P 500 eased a point to 1995. Bitcoin lost $4 to $484.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.